Stephen Schultz | VP, Investor Relations |
Justin Gover | Chief Executive Officer |
Julian Gangolli | President of North America |
Chris Tovey | Chief Operating Officer |
Volker Knappertz | Chief Medical Officer |
Scott Giacobello | Chief Financial Officer |
Salveen Richter | Goldman Sachs |
Tazeen Ahmad | Bank of America Merrill Lynch |
Phil Nadeau | Cowen & Company |
Paul Matteis | Stifel |
Cory Kasimov | JPMorgan |
Marc Goodman | SVB Leerink |
Esther Rajavelu | Oppenheimer |
David Lebowitz | Morgan Stanley |
David Kideckel | AltaCorp Capital |
Ladies and gentlemen, greetings and welcome to GW Pharmaceuticals Earnings Call for the Quarter Ended December 31st, 2018. At this time, all participants are on a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I would now like to turn the conference over to your host, Stephen Schultz, Vice President of Investor Relations, Mr.